We would love to hear your thoughts about our site and services, please take our survey here.
Interesting comments about US approval route https://www.usatoday.com/story/news/health/2023/02/08/covid-antiviral-interferon-lambda-shot/11199875002/
https://news.yahoo.com/experimental-covid-treatment-could-promising-220001007.html
https://twitter.com/fdadeviceinfo/status/1458459394392330242?s=21
Just came across this, anyone else aware of this Korean company, with a US arm?
http://m.koreaherald.com/view.php?ud=20210923000744
RNS out
I must admit that is causing me some head scratching too, Matterhorn. As a LTH I am constantly reassessing risk/reward against timescales that we are fed. To be fair to the company, this is in line with their issued info and interview comments but it does cause confusion potentially. I shall revert to company issued info I think and not place too much credence on 3rd party sites until it becomes more clear.
Came across this https://www.isrctn.com/ISRCTN85436698 with updated editorial notes at the bottom (changes made 20/07/21). These dates are not yet reflected on the NIH but appear to push into November 21. Very specific dates as opposed to the estimates on https://www.clinicaltrials.gov/ct2/show/NCT04732949
https://www.globenewswire.com/news-release/2021/07/15/2263510/0/en/Early-Results-of-BetterLife-Preclinical-Study-Showing-AP-003-rhIFNa2b-has-Similar-Potent-Efficacy-Against-Different-Variants-of-COVID-19.html
Early stage inhaled interferon trials - more evidence of their importance.....
4 cases in London and 8 in the UK recorded
https://www.mylondon.news/news/health/london-covid-cases-contagious-new-20991581
Suggests that post July 19th there will still be 17 million unprotected in the population....
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01589-0/fulltext
https://www.youtube.com/watch?v=brLQBARijn0
Proactive news 2 hrs ago - compassionate use granted